When President Trump talked on the campaign trail about reducing regulations, Washington yawned. Presidents, especially Republicans, were always promising this and never delivering. But 2018 saw fewer regulations initiated and fewer pages added to the Federal Register than any year…

by David Catron | Jan 15, 2019

When President Trump introduced the “American Patients First” blueprint for reducing drug prices, it was inevitable that the Democrats and their media enablers would immediately denounce the plan, the team that put it together, and the President himself. And, when…

Last Friday, President Trump caused consternation among Democrats and their media allies by introducing an eminently sensible blueprint for reducing drug prices. The 50-point “American Patients First” plan addresses four broad challenges: High list prices for drugs, government programs overpaying for…

Patents are one of the most miraculous legal inventions of the modern age: with a stroke of a pen, an idea that can save lives, or move mountains, can become a source of prosperity not just for the world, but…

For years America’s drugmakers relied on Republicans to protect them. Democrats led the campaign for price controls and other restrictions. So the Pharmaceutical Research and Manufacturers of America, or PhRMA, the major industry association, worked closely with the GOP to…

A bill pending in Congress would effectively serve as government-sanctioned theft and could prevent the development of future life-saving medications. H.R. 6505, The Medicare Negotiation and Competitive Licensing Act, introduced by Texas Democrat Rep. Lloyd Doggett last month, would allow…

by David Catron | May 15, 2018

When President Trump introduced the “American Patients First” blueprint for reducing drug prices, it was inevitable that the Democrats and their media enablers would immediately denounce the plan, the team that put it together, and the President himself. And, when…

Last Friday, President Trump caused consternation among Democrats and their media allies by introducing an eminently sensible blueprint for reducing drug prices. The 50-point “American Patients First” plan addresses four broad challenges: High list prices for drugs, government programs overpaying for…

Americans are suffering pharmaceutical sticker shock. But the remedy Democrats are backing — price controls on prescription drugs — would inflict more harm by halting new discoveries and dooming patients waiting for cures. Since 1950, our increasing longevity — an…

In the past week, two news items came out of the Trump White House that should trouble supporters of the President’s populist agenda, and should send warning bells about the advice that President Trump may be receiving from his inner…

Sign Up to receive Our Latest Updates! Register